Lung Adenocarcinoma Harboring Concomitant EGFR Mutation and EML4-ALK Fusion That Benefits From Three Kinds of Tyrosine Kinase Inhibitors: A Case Report and Literature Review

Lung Adenocarcinoma Harboring Concomitant EGFR Mutation and EML4-ALK Fusion That Benefits From Three Kinds of Tyrosine Kinase Inhibitors: A Case Report and Literature Review

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Clinical Lung Cancer - Volume 16, Issue 2, March 2015, Pages e5-e9

Ning Zhao, Shu-yi Zheng, Jin-ji Yang, Xu-chao Zhang, Zhi Xie, Bin Xie, Jian Su, Zhi-hong Chen, Shi-liang Chen, Na Zhang, Na-na Lou, Song Dong, Yi-long Wu,